Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances
- 1 January 1983
- journal article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 39 (1) , 62-64
- https://doi.org/10.1007/bf01960629
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.Journal of Clinical Investigation, 1981
- Glutathione: interorgan translocation, turnover, and metabolism.Proceedings of the National Academy of Sciences, 1979
- EFFECT OF DOXORUBICIN ON HEPATIC AND CARDIAC GLUTATHIONE1979
- REACTIONS OF O‐2, H2O2 AND OTHER OXIDANTS WITH SULFHYDRYL ENZYMES‡Photochemistry and Photobiology, 1978
- Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac CatheterizationAnnals of Internal Medicine, 1978
- Do Mitochondria Produce Oxygen Radicals in vivo?European Journal of Biochemistry, 1978
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Addition ofN‐acetylcysteine to linoleic acid hydroperoxideLipids, 1976
- A role for glutathione in muscle contractionCellular and Molecular Life Sciences, 1970
- A distillation method for the quantitative determination of malonaldehyde in rancid foodsJournal of Oil & Fat Industries, 1960